Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

By LabMedica International staff writers
Posted on 19 Nov 2024
Print article
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women with dense breast tissue. Photoacoustic imaging, which uses a combination of light and sound to produce detailed images of breast tissue, presents a potential solution. However, recent research has identified a major issue: skin tone bias.

Researchers from Johns Hopkins University (Baltimore, MD, USA) conducted a study to assess how skin tone affects the visibility of breast cancer targets in photoacoustic imaging. Published in Biophotonics Discovery, the research evaluated three image reconstruction methods: fast Fourier transform (FFT)-based reconstruction, delay-and-sum (DAS) beamforming, and short-lag spatial coherence (SLSC) beamforming. The study involved simulations with various wavelengths (757, 800, and 1064 nm), target sizes (ranging from 0.5 to 3 mm), and skin tones (from very light to dark).

The findings revealed that traditional methods like FFT and DAS struggled to visualize small targets in darker skin tones, particularly at 757 and 800 nm wavelengths. Targets smaller than 3 mm were especially difficult to detect, with lower signal-to-noise ratios (SNR) and contrast-to-noise ratios (gCNR). In contrast, the 1064 nm wavelength showed notable improvements, particularly when paired with SLSC beamforming, enhancing the visibility of targets across all skin tones and providing clearer images with higher SNR and gCNR values.

The study findings offer promising implications for the future of breast cancer detection. By addressing the skin tone bias, photoacoustic imaging could become a more accurate and equitable tool for early diagnosis, benefiting women of all skin tones. The study highlights the importance of considering skin tone when designing next-generation imaging systems, ensuring more inclusive healthcare solutions.

“This work was motivated by a previously poor understanding of photoacoustic imaging performance under combined variations of small target sizes and darker skin tones,” said senior and corresponding author Muyinatu Bell. “Our results are enlightening, as we now have a better understanding of advanced photoacoustic imaging techniques and associated wavelengths necessary to detect small targets.”

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Chagas Disease Test
LIAISON Chagas

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.